Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database-Reference-Cited by-同舟云学术

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

Published:2018-12 Issue:6 Volume:1 Page:467-475
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Delanoy Nicolas,Hardy-Bessard Anne-Claire,Efstathiou Eleni,Le Moulec Sylvestre,Basso Umberto,Birtle Alison,Thomson Alastair,Krainer Michael,Guillot Aline,De Giorgi Ugo,Hasbini Ali,Daugaard Gedske,Bahl Amit,Chowdhury Simon,Caffo Orazio,Beuzeboc Philippe,Spaeth Dominique,Eymard Jean-Christophe,Fléchon Aude,Alexandre Jérôme,Helissey Carole,Butt Mohamed,Priou Frank,Lechevallier Éric,Deville Jean-Laurent,Goupil Marine Gross,Morales Rafael,Thiery-Vuillemin Antoine,Gavrikova Tatiana,Barthelemy Philippe,Sella Avishay,Fizazi Karim,Baciarello Giulia,Fererro Jean-Marc,Laguerre Brigitte,Verret Benjamin,Hans Sophie,Oudard Stéphane

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference30 articles.

1. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer;Tannock;N Engl J Med,2004

2. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer;Petrylak;N Engl J Med,2004

3. Alpha emitter radium-223 and survival in metastatic prostate cancer;Parker;N Engl J Med,2013

4. Sipuleucel-T immunotherapy for castration-resistant prostate cancer;Kantoff;N Engl J Med,2010

5. Prednisone plus cabazitaxel or mitoxantrone for metastatic castration-resistant prostate cancer progressing after docetaxel treatment: a randomised open-label trial;de Bono;Lancet,2010

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Early PSA Response After Abiraterone Treatment for Metastatic Castration Resistant Prostate Cancer;2024-06-12

2. The prognostic value of Eastern Cooperative Oncology Group performance status on overall survival among patients with metastatic prostate cancer: a systematic review and meta-analysis;Frontiers in Oncology;2023-12-15

3. Taxanes Versus Androgen Receptor Therapy as Second-Line Treatment for Castrate-Resistant Metastatic Prostate Cancer After First-Line Androgen Receptor Therapy;Clinical Genitourinary Cancer;2023-06

4. A Novel Artificial Intelligence–Powered Method for Prediction of Early Recurrence of Prostate Cancer After Prostatectomy and Cancer Drivers;JCO Clinical Cancer Informatics;2022-05

5. Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review;Cancers;2022-03-31